Association Between Bone Mineral Density, Bone Turnover Markers, and Serum Cholesterol Levels in Type 2 Diabetes

• Published in: Frontiers in endocrinology (Lausanne) Vol. 9; p. 646
• Main Authors: Yang, Yinqiu, Liu, Guangwang, Zhang, Yao, Xu, Guiping, Yi, Xilu, Liang, Jing, Zhao, Chenhe, Liang, Jun, Ma, Chao, Ye, Yangli, Yu, Mingxiang, Qu, Xinhua
• Format: Journal Article
• Language: English
• Published: Switzerland Frontiers Media S.A 06.11.2018
• Subjects: bone mineral density; bone turnover markers serum cholesterol; Endocrinology; HDL-C; osteoporosis; type 2 diabetes; HDL-C; bone mineral density; type 2 diabetes; LDL-C; bone turnover markers serum cholesterol; osteoporosis; TC
• ISSN: 1664-2392; 1664-2392
• DOI: 10.3389/fendo.2018.00646

The association between bone mineral density (BMD), bone turnover markers, and serum cholesterol in healthy population has already been proved. However, in patients with type 2 diabetes mellitus (T2D), it has not been adequately analyzed. In this study, we investigated the correlation between BMD, bone turnover markers, and serum cholesterol levels in people with T2D. We enrolled 1,040 men and 735 women with T2D from Zhongshan Hospital between October 2009 and January 2013. Their general condition, history of diseases and medication, serum markers, and BMD data were collected. We used logistic regression analysis to identify the association between serum cholesterol levels and BMD as well as bone turnover markers. In multivariate regression analysis, we observed that in men with T2D, high high-density lipoprotein-cholesterol and total cholesterol levels were significantly associated with low total lumbar, femur neck, and total hip BMD, while low-density lipoprotein-cholesterol level was only inversely associated with total lumbar and femur neck BMD. Total cholesterol and low-density lipoprotein-cholesterol levels were also negatively associated with osteocalcin, procollagen type I N-terminal propeptide, and β-crosslaps. In women with T2D, high-density lipoprotein-cholesterol level was observed to be negatively correlated with total lumbar, femur neck, and total hip BMD, while total cholesterol and low-density lipoprotein-cholesterol levels were only associated with BMD at the total lumbar. Furthermore, total cholesterol was also negatively associated with osteocalcin, procollagen type I N-terminal propeptide, and β-crosslaps; high-density lipoprotein-cholesterol was only related to osteocalcin and parathyroid hormone, while low-density lipoprotein-cholesterol was only related to β-crosslaps in women. Our study suggests a significantly negative correlation between serum cholesterol levels and BMD in both men and women with T2D. The associations between serum cholesterol levels and bone turnover markers were also observed in T2D patients.